Skip to main content
Scienza Health
PRESS CENTER
Last updated: April 2026Reviewed quarterly

News & Press Releases

Company announcements, partnerships, and clinical milestones.

Product

62 Million American Employees Live With Mental Illness. 46 Percent Receive No Treatment. Scienza Health’s GIA Now Screens for Depression, Anxiety, and PTSD in 40 Seconds.

510(k) cleared lifelike Digital Human screens for depression at 81.6% accuracy, anxiety at 77.5%, and PTSD at 80% from a 40-second natural conversation in 92 languages

Sixty-two million American employees live with mental illness and 46 percent receive no treatment. Scienza Health’s GIA now screens for depression at 81.6% accuracy, anxiety at 77.5%, and PTSD at 80% from a 40-second natural conversation -- no forms, no questionnaires, no clinician required.

Product

Scienza Health’s GIA Crosses From Probabilistic to Deterministic AI -- Clinical Responses Now Grounded in 27 Billion Real Patient Outcomes

Every response GIA delivers is now benchmarked in real time against a de-identified longitudinal dataset of 27 billion clinical events and 3 million neurodegenerative patient journeys

Scienza Health’s GIA has crossed from probabilistic to deterministic AI. Every clinical response is now benchmarked in real time against 27 billion clinical events and 3 million neurodegenerative patient journeys -- grounding outputs in what actually happened to matched patients, not in what a language model predicts.

Leadership

Scienza Health Reports 14,600+ Facility Reach Following PointClickCare Marketplace Launch at HIMSS 2026

Third consecutive major conference appearance in Samsung booth caps six-month sprint from stealth debut to national EHR distribution

At HIMSS 2026, Scienza Health announced that GIA® is now accessible to more than 14,600 post-acute and long-term care facilities through the PointClickCare Marketplace — six months after her industry debut at HLTH 2025.

Partnership

Scienza Health’s GIA® Now Live in the PointClickCare Marketplace

Integration gives 14,600+ connected PAC/LTC facilities access to 46-condition multimodal clinical screening with real-time EHR write-back

Scienza Health announces that GIA®, the cleared digital human powered by digitalhumanOS™, is now live in the PointClickCare Marketplace — enabling any of PointClickCare’s 14,600+ connected facilities to deploy multimodal clinical AI screening with real-time EHR write-back.

Leadership

Scienza Health Brings Live GIA® Screening to PAC/LTC Operators at VIVE 2026

Post-acute care operators see GIA® conduct a full 46-condition screening live on stage for the first time, four months after industry debut

At VIVE 2026 in Los Angeles, Scienza Health conducted the first live, on-stage screening demonstration of GIA® for post-acute and long-term care operators — a full 46-condition conversation completed in under five minutes.

Partnership

Scienza Health and Samsung Expand GIA® to Full Galaxy Device Ecosystem

Web-based clinical screening platform now accessible on Galaxy smartphones, tablets, and Samsung DeX — no app downloads, no IT integration required

Scienza Health and Samsung expand their partnership to bring GIA® to the full Galaxy device ecosystem. The web-based platform requires no app downloads, no IT integration, and no device-specific configuration — any Samsung Galaxy device becomes a clinical screening station.

Partnership

Scienza Health and Samsung Expand Care Across Galaxy Devices

digitalhumanOS™ and ERaaS™ platform delivers ambient speech screening, automated clinical workflows, and real-time monitoring across Samsung Galaxy ecosystem

Scienza Health and Samsung announced a collaboration delivering advanced patient screening, engagement, and monitoring through Galaxy smartwatches, phones, tablets, and TVs. Covered by McKnight’s Senior Living, Morningstar, AI Journal, and Samsung Global Newsroom.

Product Launch

Scienza Health Emerges from Stealth with GIA®, the First Cleared Digital Human for Clinical Screening, at HLTH 2025

Debuting in the Samsung booth, GIA® screens for 46 clinical conditions in under five minutes using voice, vision, and speech biomarkers — with zero staff time required during the interaction

Scienza Health emerged from stealth at HLTH 2025 with GIA®, a 510(k) cleared digital human that screens for 46 clinical conditions in a single patient conversation. Debuting in the Samsung booth, GIA® is purpose-built for post-acute and long-term care.

Partnership

Scienza Health Joins AWS Partner Network to Power National Deployment of GIA®

HIPAA-compliant cloud infrastructure supports real-time Voice AI, Computer Vision, and Speech Biomarker analysis at clinical scale

Scienza Health joins the AWS Partner Network, securing the HIPAA-compliant cloud infrastructure required to scale GIA® clinical screening across thousands of post-acute and long-term care facilities nationwide.

Leadership

Samsung Selects Scienza Health for Frontline Worker Summit

Scienza Health joins select group of Samsung partners presenting to Fortune 500 companies on frontline workforce transformation

Samsung Electronics America-Healthcare selects Scienza Health to co-chair an exclusive roundtable at the Frontline Worker Innovation Summit in Mountain View, positioning the company to present GIA® to Fortune 500 healthcare leaders.

Partnership

Scienza Health and Samsung Announce Strategic Partnership to Bring GIA® to Health Grade Galaxy Devices

First partnership to bundle a 510(k) cleared clinical screening platform on Samsung’s purpose-built healthcare hardware with Knox enterprise security

Scienza Health and Samsung announce a strategic partnership to bundle GIA®, a 510(k) cleared digital human for clinical screening, on Samsung’s Health Grade Galaxy devices with Samsung Knox enterprise security.

Regulatory

Scienza Health Achieves 510(k) Clearance for digitalhumanOS™ Clinical Screening Platform

Clearance validates multimodal clinical screening using Voice AI, Computer Vision, and Speech Biomarkers for cognitive, neurological, and behavioral health conditions

Scienza Health achieves 510(k) clearance for the digitalhumanOS™ platform, validating multimodal clinical screening capabilities for cognitive, neurological, and behavioral health conditions in post-acute and long-term care.